Company Market Research Report: iLoF

Company Overview

Name: iLoF

Mission: To accelerate the era of personalized medicine through an intelligent platform for precise, patient-centric drug development.

Founded By: Luis Valente, Mehak Mumtaz, Paula Sampaio

Founded: No specific data available

Key People:

Luis Valente - CEO & Co-Founder

Mehak Mumtaz - COO & Co-Founder

Paula Sampaio - CSO & Co-Founder

Jorge Fernández García - Advisor

Derek Hill - Advisor

Pedro Jorge - Advisor

Mike Smith - Advisor

João Paulo Cunha - Advisor

Headquarters:

United Kingdom: 124 City Road, EC1V 2NX London

United States: 260 East Main Street, Suite 6380, New York, 14604

Portugal: Founders Founders Porto Oriental, Rua de Godim, 389, 1st floor, 4300-240 Porto

Number of Employees: No specific data available

Revenue: No specific data available

Known For: AI-powered platform that creates a digital library of optical biomarkers for drug development and personalized medicine.

Products

Core Platform:

Cloud-based library of optical fingerprints powered by photonics and AI.

Key Features:

Non-invasive: Utilizes minimal blood volumes for analysis.

Agnostic: Capable of flexibly targeting without labels.

Rapid: Processes samples in less than 10 seconds.

Low Cost: Functions without the need for consumables, leveraging only light and AI.

Applications:

Alzheimer's Disease: Early and differential screening capabilities.

COVID-19: Predicts clinical outcomes and symptom severity.

Ovarian Cancer: Stratifies cancer subtypes for tailored treatments.

Recent Developments

Funding: Secured $5 million to expand its digital library of biomarkers.

Achievements:

Won the Deeptech prize in Microsoft's Female Founders Competition, showcasing recognition in the tech industry.

Partnerships and Recognition: Acknowledged as a promising digital health company by CB Insights and a Transformational Business in Healthcare by the Financial Times.

Summary

iLoF stands at the forefront of personalized medicine, driven by its cutting-edge AI technology. With a mission to redefine how medicine is personalized and administered, the company leverages its innovative platform to address various complex diseases. Celebrated for its contributions and innovations in healthcare, iLoF is recognized as a pivotal player in the biotech industry.